Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
life sciences & biomedicine (45) 45
science & technology (45) 45
female (42) 42
male (41) 41
adult (39) 39
middle aged (39) 39
biological and medical sciences (28) 28
medical sciences (28) 28
aged (27) 27
hematology (26) 26
oncology (21) 21
antineoplastic combined chemotherapy protocols - therapeutic use (20) 20
hematologic and hematopoietic diseases (19) 19
adolescent (17) 17
treatment outcome (17) 17
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (16) 16
prognosis (14) 14
antineoplastic agents (13) 13
chemotherapy (13) 13
disease-free survival (13) 13
follow-up studies (11) 11
pharmacology. drug treatments (11) 11
aged, 80 and over (10) 10
cyclophosphamide - administration & dosage (9) 9
neoplasm staging (9) 9
retrospective studies (9) 9
risk factors (9) 9
survival analysis (9) 9
time factors (9) 9
abridged index medicus (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
hodgkin disease - therapy (8) 8
rituximab (8) 8
vincristine - administration & dosage (8) 8
antibodies, monoclonal, murine-derived (7) 7
doxorubicin - administration & dosage (7) 7
prednisone - administration & dosage (7) 7
young adult (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
combined modality therapy (6) 6
hodgkin disease - drug therapy (6) 6
lymphoma, large b-cell, diffuse - drug therapy (6) 6
recurrence (6) 6
antibodies, monoclonal - administration & dosage (5) 5
antineoplastic agents - therapeutic use (5) 5
cancer (5) 5
cytarabine - administration & dosage (5) 5
etoposide - administration & dosage (5) 5
hodgkin disease - pathology (5) 5
hodgkin disease - radiotherapy (5) 5
hodgkin's disease (5) 5
leukemia - etiology (5) 5
lymphoma, non-hodgkin - drug therapy (5) 5
salvage therapy (5) 5
stem cell transplantation (5) 5
tumors (5) 5
bleomycin - administration & dosage (4) 4
care and treatment (4) 4
child (4) 4
clinical trials as topic (4) 4
cyclophosphamide - adverse effects (4) 4
doxorubicin (4) 4
doxorubicin - adverse effects (4) 4
etoposide (4) 4
hodgkin disease - mortality (4) 4
lymphoma (4) 4
lymphoma, non-hodgkin - pathology (4) 4
lymphomas (4) 4
methotrexate - administration & dosage (4) 4
non-hodgkin's lymphomas (4) 4
remission induction (4) 4
survival (4) 4
thrombocythemia, essential - complications (4) 4
thrombosis (4) 4
thrombosis - etiology (4) 4
abvd (3) 3
acute leukemia (3) 3
antimitotic agents (3) 3
bleomycin - adverse effects (3) 3
cause of death (3) 3
cyclophosphamide (3) 3
general & internal medicine (3) 3
general aspects (3) 3
hodgkin disease - diagnostic imaging (3) 3
hodgkin's lymphoma (3) 3
immunochemotherapy (3) 3
italy (3) 3
italy - epidemiology (3) 3
kaplan-meier estimate (3) 3
leucovorin - administration & dosage (3) 3
leukemia (3) 3
leukemia, myeloid, acute - enzymology (3) 3
lymphoma, b-cell, marginal zone - pathology (3) 3
lymphoma, non-hodgkin - complications (3) 3
marginal zone (3) 3
medicine, general & internal (3) 3
multivariate analysis (3) 3
pipobroman (3) 3
positron-emission tomography - methods (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
by Viviani, Simonetta and Zinzani, Pier Luigi and Rambaldi, Alessandro and Brusamolino, Ercole and Levis, Alessandro and Bonfante, Valeria and Vitolo, Umberto and Pulsoni, Alessandro and Liberati, Anna Marina and Specchia, Giorgina and Valagussa, Pinuccia and Rossi, Andrea and Zaja, Francesco and Pogliani, Enrico M and Pregno, Patrizia and Gotti, Manuel and Gallamini, Andrea and Scalabrini, Delia Rota and Bonadonna, Gianni and Gianni, Alessandro M and Intergrp Italiano Linfomi and Grp Italiano Terapie Innovative Ne and Michelangelo Fdn and Michelangelo Foundation and Intergruppo Italiano Linfomi and Gruppo Italiano di Terapie Innovative nei Linfomi
The New England journal of medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Hodgkin's disease | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
by Chiappella, Annalisa and Martelli, Maurizio and Angelucci, Emanuele and Brusamolino, Ercole and Evangelista, Andrea and Carella, Angelo Michele and Stelitano, Caterina and Rossi, Giuseppe and Balzarotti, Monica and Merli, Francesco and Gaidano, Gianluca and Pavone, Vincenzo and Rigacci, Luigi and Zaja, Francesco and D'Arco, Alfonso and Cascavilla, Nicola and Russo, Eleonora and Castellino, Alessia and Gotti, Manuel and Congiu, Angela Giovanna and Cabras, Maria Giuseppina and Tucci, Alessandra and Agostinelli, Claudio and Ciccone, Giovannino and Pileri, Stefano A and Vitolo, Umberto
The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Consolidation Chemotherapy | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Risk Factors | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Intention to Treat Analysis | Vincristine - adverse effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Carmustine - administration & dosage | Stem Cell Transplantation - adverse effects | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Brentuximab vedotin in relapsed/refractory Hodgkin’s lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials
by Pier Luigi Zinzani and Simonetta Viviani and Antonella Anastasia and Umberto Vitolo and Stefano Luminari and Francesco Zaja and Paolo Corradini and Michele Spina and Ercole Brusamolino and Alessandro M. Gianni and Armando Santoro and Barbara Botto and Enrico Derenzini and Cinzia Pellegrini and Lisa Argnani
Haematologica (Roma), ISSN 0390-6078, 08/2013, Volume 98, Issue 8, pp. 1232 - 1236
Life Sciences & Biomedicine | Hematology | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Hodgkin Disease - diagnosis | General Practice - methods | Male | Hodgkin Disease - epidemiology | Secondary Prevention | Young Adult | Disease-Free Survival | Adolescent | Hodgkin Disease - drug therapy | Immunoconjugates - therapeutic use | Adult | Female | Italy - epidemiology | Aged | Retrospective Studies | Child | Index Medicus | Original and Brief Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text First-line therapy of CD20+ diffuse large B-cell lymphoma: Facts and open questions
by Brusamolino, Ercole
Haematologica (Roma), ISSN 0390-6078, 09/2009, Volume 94, Issue 9, pp. 1194 - 1198
Life Sciences & Biomedicine | Hematology | Science & Technology | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Antigens, CD20 | Lymphoma, Large B-Cell, Diffuse - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Survival Rate | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial
by Raemaekers, J.M.M and Ane, M.P and Federico, M and Girinsky, T and Oumedaly, R and Brusamolino, E and Brice, P and Ferme, C and Maazen, R.W. van der and Gotti, M and Bouabdallah, R and Sebban, C.J and Lievens, Y and Re, A and Stamatoullas, A and Morschhauser, F and Lugtenburg, P.J and Abruzzese, E and Olivier, P and Casasnovas, R.O and Imhoff, G. van and Raveloarivahy, T and Bellei, M and Borght, T. van der and Bardet, S and Versari, A and Hutchings, M and Meignan, M and Fortpied, C
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 12, pp. 1188 - 1194
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Hodgkin Disease - diagnostic imaging | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Hodgkin Disease - pathology | Humans | Middle Aged | Male | Vinblastine - administration & dosage | Chemoradiotherapy | Neoplasm Recurrence, Local - pathology | Young Adult | Hodgkin Disease - radiotherapy | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - administration & dosage | Bleomycin - administration & dosage | Positron-Emission Tomography - methods | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study
by Zinzani, Pier Luigi and Broccoli, Alessandro and Gioia, Daniela Maria and Castagnoli, Antonio and Ciccone, Giovannino and Evangelista, Andrea and Santoro, Armando and Ricardi, Umberto and Bonfichi, Maurizio and Brusamolino, Ercole and Rossi, Giuseppe and Anastasia, Antonella and Zaja, Francesco and Vitolo, Umberto and Pavone, Vincenzo and Pulsoni, Alessandro and Rigacci, Luigi and Gaidano, Gianluca and Stelitano, Caterina and Salvi, Flavia and Rusconi, Chiara and Tani, Monica and Freilone, Roberto and Pregno, Patrizia and Borsatti, Eugenio and Sacchetti, Gian Mauro and Argnani, Lisa and Levis, Alessandro
Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 12, pp. 1376 - 1385
Life Sciences & Biomedicine | Oncology | Science & Technology | Hodgkin Disease - diagnostic imaging | Predictive Value of Tests | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Positron-Emission Tomography | Patient Selection | Young Adult | Time Factors | Hodgkin Disease - mortality | Adult | Female | Stem Cell Transplantation - mortality | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Italy | Aged | Drug Substitution | Neoplasm Staging | Stem Cell Transplantation - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers
by Francesco Zaja and Stefano De Luca and Umberto Vitolo and Lorella Orsucci and Alessandro Levis and Flavia Salvi and Chiara Rusconi and Erika Ravelli and Alessandra Tucci and Chiara Bottelli and Monica Balzarotti and Ercole Brusamolino and Maurizio Bonfichi and Stefano A. Pileri and Elena Sabattini and Stefano Volpetti and Chiara Monagheddu and Angelo Vacca and Roberto Ria and Renato Fanin
Haematologica (Roma), ISSN 0390-6078, 03/2012, Volume 97, Issue 3, pp. 416 - 422
Dexamethasone | Salvage treatment | Lenalidomide | Relapsed/refractory disease | Mantle cell lymphoma | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Biomarkers - metabolism | Tumor Microenvironment - drug effects | Recurrence | Dexamethasone - administration & dosage | Humans | Middle Aged | Salvage Therapy | Lymphoma, Mantle-Cell - drug therapy | Male | Treatment Outcome | Thalidomide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Lymphoma, Mantle-Cell - mortality | Thalidomide - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Female | Aged | Neovascularization, Pathologic - metabolism | Index Medicus | dexamethasone | refractory disease | Original and Brief Reports | relapsed | mantle cell lymphoma | lenalidomide | salvage treatment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 study
by Martelli, Maurizio and Ceriani, Luca and Zucca, Emanuele and Zinzani, Pier Luigi and Ferreri, Andrés J. M and Vitolo, Umberto and Stelitano, Caterina and Brusamolino, Ercole and Cabras, Maria Giuseppina and Rigacci, Luigi and Balzarotti, Monica and Salvi, Flavia and Montoto, Silvia and Lopez-Guillermo, Armando and Finolezzi, Erica and Pileri, Stefano A and Davies, Andrew and Cavalli, Franco and Giovanella, Luca and Johnson, Peter W. M
Journal of clinical oncology, ISSN 0732-183X, 06/2014, Volume 32, Issue 17, pp. 1769 - 1775
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Leucovorin - administration & dosage | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Tomography, X-Ray Computed - methods | Male | Lymphoma, Large B-Cell, Diffuse - diagnostic imaging | Mediastinal Neoplasms - drug therapy | Multimodal Imaging - methods | Vincristine - administration & dosage | Adult | Female | Radiopharmaceuticals | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Rituximab | Bleomycin - administration & dosage | Mediastinal Neoplasms - diagnostic imaging | Positron-Emission Tomography - methods | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Survival Analysis | Fluorodeoxyglucose F18 | Methotrexate - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A Prognostic Score for Advanced Hodgkin's Disease
by Hasenclever, Dirk and Diehl, Volker and Armitage, James O and Assouline, David and Björkholm, Magnus and Brusamolino, Ercole and Canellos, George P and Carde, Patrice and Crowther, Derek and Cunningham, David and Eghbali, Houchingue and Ferm, Christophe and Fisher, Richard I and Glick, John H and Glimelius, Bengt and Gobbi, Paolo G and Holte, Harald and Horning, Sandra J and Lister, T. Andrew and Longo, Dan L and Mandelli, Franco and Polliack, Aaron and Proctor, Stephen J and Specht, Lena and Sweetenham, John W and Hudson, Gillian Vaughan and Int Prognostic Factors Project Adv Hodgkins Dis
The New England journal of medicine, ISSN 0028-4793, 11/1998, Volume 339, Issue 21, pp. 1506 - 1514
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Hodgkin's disease | Prognosis | Clinical trials | Medical research | Neurological disorders | Predictions
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
by Passamonti, Francesco and Rumi, Elisa and Arcaini, Luca and Boveri, Emanuela and Elena, Chiara and Pietra, Daniela and Boggi, Sabrina and Astori, Cesare and Bernasconi, Paolo and Varettoni, Marzia and Brusamolino, Ercole and Pascutto, Cristiana and Lazzarino, Mario
Haematologica (Roma), ISSN 0390-6078, 11/2008, Volume 93, Issue 11, pp. 1645 - 1651
Thrombocythemia | Myelofibrosis | Prognosis | Polycythemia | Leukemia | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Polycythemias | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Diseases of red blood cells | Leukemia - physiopathology | Thrombosis - physiopathology | Follow-Up Studies | Humans | Middle Aged | Primary Myelofibrosis - physiopathology | Risk Factors | Janus Kinase 2 - genetics | Primary Myelofibrosis - etiology | Thrombosis - epidemiology | Myeloproliferative Disorders - genetics | Disease Progression | Leukemia - etiology | Time Factors | Thrombosis - etiology | Primary Myelofibrosis - epidemiology | Aged | Mutation | Leukemia - epidemiology | Thrombocythemia, Essential - complications | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Long-term Events in Adult Patients with Clinical Stage IA-IIA Nonbulky Hodgkin's Lymphoma Treated with Four Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Adjuvant Radiotherapy: A Single-Institution 15-Year Follow-up
by Ercole Brusamolino and Ambrogia Baio and Ester Orlandi and Luca Arcaini and Francesco Passamonti and Vassiliki Griva and William Casagrande and Cristiana Pascutto and Pietro Franchini and Mario Lazzarino
Clinical cancer research, ISSN 1078-0432, 11/2006, Volume 12, Issue 21, pp. 6487 - 6493
ABVD | Leukemias and lymphomas | Late toxicity | Adjuvant Radiotherapy | Hodgkin's lymphoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Follow-Up Studies | Dacarbazine - therapeutic use | Humans | Middle Aged | Neoplasms, Radiation-Induced - etiology | Male | Vinblastine - therapeutic use | Lung Diseases - etiology | Bleomycin - therapeutic use | Vinblastine - adverse effects | Cardiovascular Diseases - epidemiology | Fertility - drug effects | Hodgkin Disease - mortality | Adult | Female | Fertility - radiation effects | Radiotherapy, Adjuvant | Cardiovascular Diseases - etiology | Bleomycin - adverse effects | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Pregnancy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Survival Analysis | Neoplasms, Radiation-Induced - epidemiology | Doxorubicin - adverse effects | Lung Diseases - epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
by Passamonti, Francesco and Rumi, Elisa and Pungolino, Ester and Malabarba, Lucia and Bertazzoni, Paola and Valentini, Marina and Orlandi, Ester and Arcaini, Luca and Brusamolino, Ercole and Pascutto, Cristiana and Cazzola, Mario and Morra, Enrica and Lazzarino, Mario
The American journal of medicine, ISSN 0002-9343, 2004, Volume 117, Issue 10, pp. 755 - 761
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Prognosis | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Polycythemia Vera - mortality | Polycythemia Vera - complications | Life Expectancy | Thrombocythemia, Essential - mortality | Survival Analysis | Female | Italy - epidemiology | Thrombocythemia, Essential - complications | Survival analysis | Cardiovascular disease | Life expectancy | Regression analysis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights